Corneal autofluorescence, as measured with a commercial scanning fluorophot
ometer (lambda(exc): 415-491 nm; lambda(em): 515-630 nm), is increased in p
atients with diabetes mellitus. However, such fluorophotometers register an
average fluorescence signal over all corneal layers as a consequence of th
eir limited axial resolution of 0.5 mm. In order to determine the location
of the fluorophores responsible for the increased corneal autofluorescence
measured in diabetics, an attempt was made to measure in vivo the distribut
ion of autofluorescence along the optical axis of the cornea with a modifie
d slitlamp. Fluorescence excitation and emission filters identical to those
of the scanning fluorophotometer were fitted to a slitlamp equipped with a
slow scan CCD camera. Corneal autofluorescence intensity profiles were obt
ained with the slitlamp in five patients with severe diabetic retinopathy a
nd compared to those of age-matched healthy controls. Corneal autofluoresce
nce was also measured with the scanning fluorophotometer for comparison. Th
e resolution of the CCD camera for measurement of fluorescence along the co
rneal axis was 0.1 mm. The corneal autofluorescence intensity of the patien
ts and the healthy controls gradually decreased by about the same amount fr
om the endothelium to the epithelium (57% mm(-1) +/- 6 S.D. and 52 % mm(-1)
+/- 5 S.D., respectively). The area under the fluorescence intensity curve
was significantly greater for the patients than for the healthy controls (
factor 2.4 +/- 1.0 S.D., P < 0.001) and was proportional to the corneal flu
orescence measured with the scanning fluorophotometer (r = 0.92, P < 0.001)
. The results show that (1) the distribution of autofluorescence along the
corneal axis can be measured in vivo in humans, (2) the fluorophores involv
ed are distributed throughout the cornea, and (3) the relative distribution
of fluorescence is similar in diabetic patients and healthy controls. (C)
1999 Academic Press.